Skip to Main Content

Paper Details

A Phase 2, Double-blind, Randomized Controlled Trial of PROSTVAC in Prostate Cancer Patients on Active Surveillance.
Eur Urol Focus
1
2023
AS, CD4, CD8, PROSTVAC, PSA, Participants, Patients, Prostate Cancer, T-, T-cell, antigen-specific T cells, localized prostate cancer, men, participant, patients, peripheral, peripheral T-cell, prostate cancer, serum PSA, tumor
Author NameAffiliation
John K Parsonsuniversity of california san diego Moores Cancer Center
Christian P PavlovichBrady Urological Institute, Johns Hopkins School of Medicine
Julie E BaumanUniversity of Arizona Cancer Center
  • 1 - 3

Datasets

Release 1.2